Pharma Finance and Investment News
Novartis Invest $256 million in Singapore Biopharmaceutical Manufacturing Facility
Novartis recently announced it broke ground for the $256 million expansion of its biopharmaceutical manufacturing plant in Singapore. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Tubulis Closes €128 Million Series B
Tubulis have announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
CryoLogyx Completes £500k Seed Funding Round
CryoLogyx, a University of Warwick spinout redefining cell technology through cryopreservation, have announced the close of its oversubscribed seed funding round. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Zephyr AI Raises $111 Million in Series A Financing
Zephyr AI, Inc. have announced it has successfully closed a $111 million Series A funding round with participation from Revolution Growth, Eli Lilly & Company, Jeff Skoll, and EPIQ Capital Group, among others. Read more
15 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Biocon Biologics enters a commercial collaboration with Eris Lifesciences
Biocon Biologics Limited have announced a long -term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of Metabolics, Oncology, and Critical Care products in India. Read more
15 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Mission Therapeutics raises £25.2 million
Mission Therapeutics have announced it has raised £25.2 million to progress the clinical development of its drug candidates. Read more
14 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
AstraZeneca to acquire Amolyt Pharma
AstraZeneca announced that it has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases. Read more
14 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Sionna Therapeutics Announce $182 Million Series C Financing
Sionna Therapeutics have announced the closing of a $182 million Series C financing. Read more
12 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Samsung BioLogics and UCB Sign Third Drug Manufacturing Deal
Samsung BioLogics and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB's anti-tau candidate to treat progressive supranuclear palsy, pending regulatory approvals. Read more
8 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Novartis Invest $256 million in Singapore Biopharmaceutical Manufacturing Facility
Novartis recently announced it broke ground for the $256 million expansion of its biopharmaceutical manufacturing plant in Singapore. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
European Commission Approves Pfizer’s PREVENAR 20
Pfizer Inc have announced that the European Commission (EC) has granted marketing authorisation for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20. Read more
18 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
ReciBioPharm and GeneVentiv Therapeutics to Partner
ReciBioPharm, the advanced and emerging therapies business unit of Recipharm, has announced a collaboration agreement with GeneVentiv Therapeutics to advance development of an Adeno-Associated Virus (AAV)-based universal gene therapy for haemophilia. Read more
18 Mar 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Tubulis Closes €128 Million Series B
Tubulis have announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
CryoLogyx Completes £500k Seed Funding Round
CryoLogyx, a University of Warwick spinout redefining cell technology through cryopreservation, have announced the close of its oversubscribed seed funding round. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
FDA Approves Bristol Myers Squibb’s Breyanzi
Bristol Myers Squibb have announced the U.S FDA has granted accelerated approval of Breyanzi (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia. Read more
18 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25